Two patients with the same diagnosis are seldom impaired to the same extent. While the number and degree of symptoms described by patients are only weakly related to the underlying pathology, they correlate well with the extent of subjective impairment. This is true not only for low back pain, 1-6 but also for other conditions such as rheumatoid arthritis 7 and asthma. 8 We suspect that the tendency to somatise influences the outcome of treatment. It has previously been established that the outcome is not merely related to the efficacy of the treatment. Psychological and social factors such as working practice, the domestic environment and associated compensation claims also have influence and have been shown to be better predictors of outcome than clinical and imaging findings.
Two patients with the same diagnosis are seldom impaired to the same extent. While the number and degree of symptoms described by patients are only weakly related to the underlying pathology, they correlate well with the extent of subjective impairment. This is true not only for low back pain, [1] [2] [3] [4] [5] [6] but also for other conditions such as rheumatoid arthritis 7 and asthma. 8 We suspect that the tendency to somatise influences the outcome of treatment. It has previously been established that the outcome is not merely related to the efficacy of the treatment. Psychological and social factors such as working practice, the domestic environment and associated compensation claims also have influence and have been shown to be better predictors of outcome than clinical and imaging findings. [9] [10] [11] [12] [13] [14] [15] A uniform picture of these predictors has, however, not emerged, nor have these factors been assessed on the basis of empirical investigations.
As an indirect measure of outcome, the questionnaire on the health-related quality of life, the Short-Form 36 of the WHO (SF-36), 16 provides an economical and valid instrument. Studies which have used this assessment in patients with back pain have shown its validity and reliability as well as its suitability for investigating the course of disc disease and its treatment. 9, 17, 18 The body-related dimensions of the SF-36 correlated well with specific instruments for assessing impairment in patients with back pain, 11, 15 using visual analogue scales (VAS) for self-reporting, as well as objective parameters such as the return to work. 12 Hollingworth et al 19 found no relationship between the extent of disc disease, neural impingement and quality of life (SF-36) assessed at the start of treatment. They investigated the relationship between the extent of the pathology and the quality of life in low back pain. Our study assesses the influence of somatisation on the quality of life and outcome of treatment in patients with disc disease.
Patients and Methods
We examined 109 consecutive inpatients with low back pain, with or without sciatica, within the first two days of admission, immediately before discharge, and one year after the conclusion of treatment. Patients treated both by operation and conservatively were included in the study. Those with psychiatric or other chronic conditions were excluded as were patients with tumours. There were 65 men and 44 women with a mean age of 43.4 years. The median duration of symptoms was 24 months (3 to 91). We included patients with differing degrees of disc disease and neural compression and those with no clinical or radiological abnormalities. Radiographs of the lumbar spine were taken routinely in two planes. The patients also had either CT or MRI. Those who had undergone previous surgery had MRI with the addition of contrast medium to distinguish between a further prolapse and scar tissue. In patients with no acute or deteriorating muscular weakness an inpatient treatment programme was begun, mainly involving the mobilisation techniques described by McKenzie, 20 Cyriax, 21 Maitland 22 and Betz and Meurer. 23 Appropriate medication for pain was also given. Those patients with disc-related lumbar pain and sciatica who did not respond to this conservative treatment within two weeks underwent an open unilateral nucleotomy. 24 The extent of somatisation was assessed using the Screening for Somatoform Disorders Questionnaire. 25 which is a 36-item self-rating questionnaire. 16 There are eight subscales: physical functioning, physical role limitation, bodily pain, general health, vitality, social functioning, emotional role limitation, and emotional well-being. The questionnaire allows an assessment of limitations in various aspects of life. The results were computed as Z values according to the equation Z = (Xi -) ⁄SD where Xi is the age-and gender-specific population mean. A Z value of zero means that it is identical to the mean in the normal age-and gender-matched population; a value of -1 is one SD below. 27 The transformation was undertaken for two reasons. First, it is known that, in some aspects, the healthrelated quality of life decreases differently with age and is gender-related. Secondly, reference values are at different levels for the different subscores. 26 To assess the subjective outcome of treatment a visual analogue score (VAS) was added, with a score of 100 implying maximum impairment and a score of 0 as no impairment. The patients were thus able to report their limitations because of pain before treatment, at the end of inpatient treatment, and one year after the conclusion of treatment. This variable was dichotomised; the treatment was deemed a success if the score showed improvement of at least 50% from the baseline. This has been described in earlier studies as a practicable and valid outcome measure.
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Statistical analysis. In order to compare the change in health-related quality of life (baseline to follow-up) as well as the change in somatisation paired Student t-tests were used, and means and 95% confidence intervals (CI) were reported. Correlations were tested parametrically (Pearson), and for variables with distinct deviation from the normal distribution a logarithmic transformation (In raw value +1 ) was initially calculated. Chi-squared tests were used for binary variables. Independent samples were compared with two-sample Student t-tests, and in cases of non-normal distribution (previous inpatient treatment, duration of illness, 'doctor shopping', time out of work during the previous past two years), non-parametric tests (Mann-Whitney U) were used. In addition, logistic regression analysis was calculated to weight the extent of the connection between somatisation and outcome, as well as the investigation of purely correlative connections. For the variables with a distinct deviation from the normal distribution (previous inpatient treatment, duration of illness, 'doctor shopping'), which were included in the backward stepwise logistic regression analysis, a logarithmic transformation (In raw value +1 ) was also done. All tests were two-tailed at a significance level of alpha <0.05.
Results
After one year 81 of the patients (74.3%) were examined again. When comparing the 42 with a good outcome after treatment (pain reduction >50%) to the 39 in whom it was poor (pain reduction <50%), there were no significant differences regarding age, gender, marital status, number of manual workers, formal education level, or employment (Table I ). The duration of symptoms significantly affected the outcome (p = 0.02); patients with a poor outcome experienced a significantly longer median period of symptoms of 56.0 months (3.0 to 123) compared with those with a good outcome (6.5 months; range 3.0 to 63.5). Both groups also differed regarding the number of weeks of treatment in hospital, the number of previous operations, and the number of physicians consulted. Before treatment all patients had considerable impairment of their quality of life, both physically and mentally. Compared with an age-and gendermatched normal population, the differences were primarily physical (physical functioning and physical role limitation). At follow-up the quality of life for all patients had improved significantly (p < 0.001), with the exception of the dimension, emotional role limitations (Fig. 1) .
The quality of life in the areas of physical functioning, physical role, and bodily pain, however, was more impaired when compared with the age-and gender-matched normal population. In the area of general health and on all mental dimensions (scales 5 to 8), the health-related quality of life fell within the normal range (Fig. 1) . The absence of a significant change on the emotional role limitations scale is probably due to the relatively low level of impairment at the start of treatment.
The parameters of chronicity correlated with the quality of life, measured by the SF-36, with regard to the bodyrelated dimensions and the vitality scale of the mental quality of life (Table I) . There was no correlation between either duration of illness or 'doctor shopping', with vitality (r = 0.16, p = 0.19 and r = 0.20, p = 0.007, respectively). The more pronounced the chronicity, the poorer was the quality of life. The age at the onset of symptoms also correlated with bodily pain (r = 0.30, p = 0.007).
Somatisation (Table II) , which was measured by screening for somatoform disorders, before treatment, correlated significantly with the physical functioning, general health and vitality scales and the emotional well-being of the SF-36 baseline (r = -0.26 to -0.38, p = 0.02 and <0.001). Thus the greater the somatisation, the poorer was the quality of life in these dimensions. The somatisation assessed at follow-up correlated negatively with all dimensions of the physical and mental quality of life (r = -0.35 to -0.51, p = 0.001 and <0.001).
The reduction of pain, as measured using VAS, correlated well with all physical scales (r = 0.70 to 0.52, p < 0.001) and to a less extent with the mental scales (r = 0.50 to 0.35, p < 0.001 and 0.002) of the SF-36 (Table II) .
Patients with a good subjective outcome had signifi- cantly fewer (p < 0.001, see Fig. 2 ) physical symptoms, both before starting treatment and at follow-up when compared with patients with a poor outcome (Fig. 2 , Table III) . Patients with a poor outcome had a mean of 7.1 (CI = 5.5 to 8.6) symptoms before treatment compared with 3.4 (CI = 2.5 to 4.5) in those with a good reduction of pain (p < 0.001, see Fig. 2 ). At follow-up this was almost unchanged; 7.3 (CI = 5.7 to 8.8) symptoms compared with 2.8 (CI = 2.0 to 3.7) (p < 0.001, see Fig. 2 ).
Based on a logistic regression analysis into which the parameters of chronicity and the extent of somatisation before the start of treatment were entered, we were able to classify a proportion of patients correctly. When all possible explanatory variables (Table I) were tested, only two remained in the equation. Using the factors somatisation (p < 0.001), and 'doctor shopping' (p = 0.003) correct total classification was possible in 82% of patients (Table IV) . Both odds ratios are greater than 1; this means that there is a higher risk of patients with somatisation and/or 'doctor shopping' belonging to the group with a poor outcome.
Discussion
Our results explore the influence of somatisation on the outcome of treatment in patients with lumbar disc disease. Taking into account easily identified features of the presenting history, such as the number of previous treatments and the duration of symptoms, we tried to establish whether the outcome of treatment can be predicted using a psychometric procedure for assessing somatisation. As a parameter of outcome, the health-related quality of life was measured by the SF-36 and a VAS for the severity of pain before treatment and at follow-up.
A limitation of the study is that the patients were not examined using a standardised interview procedure for Number of symptoms reported at baseline and follow-up by patients in the two outcome groups; > or <50% reduction in low back pain. A strength of the study, apart from the prospective design, is the implementation of proven and standardised questionnaires, and the good comparability of the results with other studies. 17, 30 The study covers a period of one year and 75% of the patients were examined at follow-up.
Those who participated and those who were lost to followup did not differ with respect to the relevant baseline psychosocial, psychometric and medical parameters. The screening to assess somatoform disorders has been validated on a large number of patients and tested for various somatic and psychosomatic groups. 25, 31 The quality of life of patients with chronic back pain is considerably impaired. This applies more to the physical domain of the health-related quality of life than the mental domain. After inpatient treatment, the quality of life of the patients improved significantly in all areas up to the time of follow-up, with the exception of the emotional role limitations (SF-36) dimension, in which the difference, compared with the normal population, was small.
Our study shows that while patients with sciatica generally improve regardless of the treatment given and whether there are abnormal clinical or imaging findings, somatisation predicts the outcome of treatment. The number of somatic symptoms at the start of treatment was the central factor in deciding the outcome of treatment in patients with sciatica. The scores for somatisation appear to be stable with the passage of time despite the distinct improvement in the quality of life.
Thus somatisation affects not only the reduction of pain, but also important aspects of the quality of life before and after treatment. Factors of chronicity, such as the number and length of hospital stays, 'doctor shopping', and the number of operations also correlate well with the quality of life at follow-up. The criteria for a good outcome was a reduction of pain by at least 50% on a VAS assessed before the start of treatment. The reduction of pain, based on a VAS, correlates well with all subscales of the SF-36, in particular the body-related dimension (r = 0.52 and 0.70, p < 0.001).
The extent of somatisation measured before the start of treatment can predict the outcome. The characteristic 'doctor shopping' is also relevant within a logistic regression analysis. Only these two factors predict outcome in 82% of patients, with those with somatisation and 'doctor shopping' at a higher risk for a poor outcome.
The establishment of a short and easily administered screening instrument which covers at least the most important psychopathological aspects, 1, 5, [12] [13] [14] 29 especially the tendency to somatise, could be used to assess difficult patients. If administered at an early stage of treatment these patients could undergo more extensive psychometric testing. In this way further chronicity of the symptoms could be avoided. The necessity of treatment would not be determined primarily by the extent of the psychopathology of the patient, or their tendency to somatise. Even 'somatisers' may have a herniated disc with compression of a nerve root and abnormal neurological findings. Depending on the clinical examination and imaging findings, they require appropriate treatment. The assessment of the tendency to somatise, poor ability to cope with illness, or clear psychosocial stress factors can, however, be of help in order to intervene preventatively and, in the case of high-risk patients, to instigate early psychosomatic treatment.
Interdisciplinary co-operation or at least the early counselling of patients with back pain by a psychiatrist is essential. Just as the clinical information from orthopaedic and neurological examinations and diagnostic aids are required, so too should the psychological and social aspects be increasingly used in the diagnosis and planning of treatment.
Our investigation indicates that the greater the tendency to somatise, the lower is the health-related quality of life at follow-up as measured on the SF-36. Patients with a greater tendency to somatise have less reduction of pain at followup and those with greater chronicity, defined as the length and number of hospital stays, previous surgery, and 'doctor shopping', at the initiation of treatment have a poorer quality of life at follow-up.
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